Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Drug Name||mRNA 5671|
mRNA 5671 is a lipid nanoparticle encapsulated mRNA vaccine that targets KRAS G12D, G12V, G13D, and G12C, which potentially results in anti-tumor immune response (NCI Drug Dictionary).
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|mRNA 5671||mRNA 5671||0||1|
|mRNA 5671 + Pembrolizumab||Pembrolizumab mRNA 5671||0||1|